PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease

Abstract EN

The aim of the study was to estimate association of the extent of angiographically proven coronary artery disease (CAD) with plasma 8-isoprostane F2 (8-iso-PGF2α) levels as a reliable marker of lipid peroxidation and serum activity of paraoxonase-1, which demonstrates the ability to protect against lipid oxidation.

The study included 105 patients with angiographically documented CAD (CAD+) and 45 patients with negative results of coronary angiography (CAD−).

Compared to the control group CAD+ patients were characterized by increased 8-iso-PGF2α levels ( P = 0.007 ) and reduced activity of PON-1 towards paraoxon (PONase, P = 0.002 ) and phenyl acetate (AREase, P = 0.037 ).

Univariate correlation analysis indicated that 8-iso-PGF2α concentrations were positively associated with the severity of CAD as evaluated by the Gensini score ( R = 0.41 , P < 0.001 ) while PONase activity ( R = − 0.26 , P < 0.05 ) and AREase activity ( R = − 0.23 , P < 0.05 ) were inversely correlated with CAD severity.

PONase activity and 8-iso-PGF2α concentration remained independent determinant of atherosclerosis severity in multiple linear regression after adjusting for age, gender, smoking habits, hypertension, type 2 diabetes, statin therapy, and HDL-C and TAG concentration ( β coefficients −0.267; P < 0.05 and 0.368; P < 0.001 , resp.).

The results suggest that PON-1 activity and 8-iso-PGF2α concentration are associated with the presence and extent of coronary stenosis and may be considered additional markers of coronary artery disease.